|
|
Volumn 8, Issue 1, 2000, Pages 85-90
|
|
Angiotensin-converting enzyme inhibition after myocardial infarction
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOTENSIN;
ANGIOTENSIN I;
BRADYKININ;
BRADYKININ B2 RECEPTOR ANTAGONIST;
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
FOSINOPRIL;
ICATIBANT;
LISINOPRIL;
LOSARTAN;
MOEXIPRIL;
NITRATE;
RAMIPRIL;
RAMIPRILAT;
CLINICAL TRIAL;
DIABETIC NEPHROPATHY;
DRUG ANTAGONISM;
DRUG INHIBITION;
DRUG MECHANISM;
DRUG POTENTIATION;
ENDOTHELIUM CELL;
ENZYME INHIBITION;
HEART FAILURE;
HEART FUNCTION;
HEART HYPERTROPHY;
HEART INFARCTION;
HEART INFARCTION SIZE;
HEART OUTPUT;
HUMAN;
HYPERTENSION;
NONHUMAN;
REVIEW;
SURVIVAL RATE;
TREATMENT PLANNING;
|
|
EID: 0034010428
PISSN: 02184923
EISSN: None
Source Type: Journal
DOI: 10.1177/021849230000800125 Document Type: Review |
|
Times cited : (3)
|
|
References (41)
|
